BioRes Dentech Unveils Innovative Ruizhi BLC Implant System in China
BioRes Dentech's Ruizhi BLC Implant System: A Breakthrough in Dental Implants
In March 2025, BioRes Dentech Inc. introduced its Ruizhi BLC Implant System at the highly anticipated Dental South China 2025 event. This implant system, developed in collaboration with Besmile, is specifically designed for the Chinese market, aiming to meet the increasing demand for superior dental implants. With a focus on advanced technology and clinical performance, this system promises to reshape the landscape of precision implantology in China.
Addressing Market Needs
The dental implant market in China has witnessed significant growth, but the penetration rate remains relatively low—standing at 59.1 implants per 10,000 people in 2023. This figure is considerably below levels observed in more developed countries like the U.S. and South Korea. The potential for growth in the Chinese market is immense; in 2024, the sector generated approximately USD 391.4 million in revenue, and projections estimate this will soar to USD 618.9 million by 2030. Factors such as bulk procurement initiatives, which have successfully reduced implant costs by 55%, contribute to this optimistic outlook.
However, the market is still grappling with a scarcity of affordable, high-quality implants that ensure long-term stability. This situation gives rise to significant concerns regarding failure rates and associated complications, underlining the importance of innovative solutions like the Ruizhi BLC Implant System.
Ruizhi BLC Implant System: Features and Benefits
In response to the existing challenges, the Ruizhi BLC Implant System has been engineered to provide lifelong stability while reducing the risks of pain and gum diseases. The system enhances ease of use for clinicians, allowing for streamlined procedures. Its cutting-edge bone preservation technology promotes the retention of alveolar bone, which is critical for maintaining peri-implant tissue stability over time.
The self-tapping design of the Ruizhi implant enhances its initial stability and overall safety, making it an efficient option that addresses the pressing needs of the market. This innovative implant system has been meticulously validated through extensive clinical trials, showcasing an impressive 0% mechanical complication rate over a span of four years and a 99.05% success rate over five years. These statistics significantly surpass the industry average of 94% to 96%, establishing the Ruizhi BLC Implant System as a new standard in dental implant treatments.
About BioRes Dentech Inc.
Located in Walnut, California, BioRes Dentech Inc. is committed to advancing dental health through innovative technology. The company strives to support oral health professionals and promote improved patient outcomes globally.
Besmile: Partnering for Success
Chengdu Besmile Biotechnology Co., Ltd. specializes in dental CAD/CAM materials, reading technologies, and implant systems. With a focus on digital solutions for dental laboratories and practices, Besmile boasts in-house research and development and an advanced manufacturing process. They have cultivated partnerships with over 1,000 clients across 100+ countries, aspiring to lead the global dental industry through groundbreaking innovations and unwavering commitment to excellence.
In conclusion, as BioRes Dentech Inc. propagates its Ruizhi BLC Implant System, the potential for transforming dental implant services in China is substantial. This cutting-edge technology not only meets the rising demand for high-quality dental solutions but also enhances the overall patient care experience, setting a new benchmark within the industry.